Acupuncture Therapy and Hypertension
Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will not be on hypertensive medications. The course last for 8 weeks and the frequency is once a week.
Conditions:
🦠 Mild to Moderate Hypertension
🗓️ Study Start (Actual) 1 January 2023
🗓️ Primary Completion (Estimated) 31 March 2026
✅ Study Completion (Estimated) 31 March 2027
👥 Enrollment (Estimated) 120
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Irvine, California, United States
📍 Orange, California, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. Subjects from 50 to 75 years of age
    • 2. Clinically diagnosed with mild to moderate hypertension and NOT on medication (Office SBP \> 140 mmHg and \< 160 mmHg Or ABPM average SBP \> 130 mmHg and \< 145 mmHg), and
    • 3. No significant ECG change reflecting ischemia (i.e. ST elevation or depression) at rest will be recruited to participate in this study.

    Exclusion Criteria:

    • 1. Subjects will be excluded if on anti-hypertensive medications.
    • 2. Subjects will be excluded if pregnant or nursing.
    • 3. Subjects will be excluded if they have coronary disease (by history or on ECG screening), conduction abnormalities on ECG consistent with left bundle branch block, cardiac arrhythmias associated with low blood pressure (\<90 mmHg), peripheral vascular disease, orthopedic disease, diabetic neuropathy or severe hypertension (BP \>170 mmHg systolic or \>110 mmHg diastolic), or any other physical or psychological illness.
    • 4. Those with known sensitivity to any topical preparations or strong reactions to medical dressings and skin tapes also will be excluded.
    • 5. Inability our or unwillingness of individual to give written informed consent.
Ages Eligible for Study: 50 Years to 75 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 27 August 2022
  • First Submitted that Met QC Criteria 1 September 2022
  • First Posted 7 September 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 15 June 2023
  • Last Update Posted 18 June 2023
  • Last Verified June 2023